GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
No bill # assigned - Trans-Pacific Strategic Economic Partnership Agreement (TPP) - provisions related to intellectual property, market access and public health H.R.6083 - Federal Agriculture Reform and Risk Management Act of 2012 - provisions related to WTO Brazil Cotton dispute S.3240 - Agriculture Reform, Food and Jobs Act of 2012 - provisions related to WTO Brazil cotton dispute No bill # assigned - Mexico and Canada IP and market access issues in context of invitation to join TPP negotiations No bill # assigned - EU/US trade liberalizing agreement No bill # assigned - International market access and intellectual property issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| SHIRA KILCOYNE | — |
| JOSEPH MCGOWAN New | None |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| EDYTA WIESNER | — |
| KIMBERLY A WILLIAMS | — |
Taxation/Internal Revenue Code TAX
S.3144 - "Temporary duty suspension for Preparations, such as tablets or chewing gum, intended to assist smokers to stop smoking (provided for in subheading 2106.90.99) " H.R.942 - American Research and Competitiveness Act of 2011 - provisions relating to the research and development tax credit
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN New | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Copyright/Patent/Trademark CPT
S. 1882 - Fair and Immediate Release of Generic Drugs Act - provisions related to patent settlements H.R. 3995 - Protect Consumer Access to Generic Drugs Act - provisions related to patent settlements HR 3497 - MODERN Cures Act of 2011 - provisions related to data protection S.27 - Preserve Access to Affordable Generics Act - provisions related to patent settlements H.R. 741 - To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs - provisions relating to authorized generics H.R. 2182, S.1734 - Generating Antibiotic Incentives Now Act of 2011 - implementation of provisions related to antibiotics and incentives S.373 - The Fair Prescription Drug Competition Act - provisions related to authorized generics S. 1882 - The Fair and Immediate Release of Generic Drugs Act - provisions related to patent settlements No bill # assigned - International intellectual property issues No bill # assigned - Biopharmaceutical innovation policy issues No bill # assigned - Technical corrections to the America Invents Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN New | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Health Issues HCR
S.2236 - Advancing Breakthrough Therapies for Patients Act of 2012 - provisions related to FDA regulation S.2113 - Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act - provisions related to accelerated approval and other FDA matters S. 2289 - The Better Pharmaceuticals and Devices for Children Act - "Provisions related to amending the Federal Food, Drug, and Cosmetic Act with respect to pediatric provisions" H.R.4274 - BPCA and PREA Reauthorization Act of 2012 - Provisions related to amending title IV of the Public Health Service Act and title V of the Federal Food, Drug, and Cosmetic Act to permanently extend the provisions of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act H.R.4156, S.2281 - Expanding and Promoting Expertise in Rare Treatments Act of 2012 - provisions related to strengthening the FDA's ability to seek advice from external experts regarding rare diseases H.R.4132 - FAST Act - provisions related to accelerated approval and other FDA matters H.R.3839 - Drug Shortage Prevention Act of 2012 - provisions related to prescription drug shortages H.R.2674 - 340B Program Improvement Act - provisions related to the 340B program PL 111-148, PL 111-152 - Patient Protection and Affordable Care Act - ACA implementation, Independent Payment Advisory Board (IPAB), comparative effectiveness, health information technology, disease prevention/wellness, sunshine and innovation provisions H.R.2405, S.1855 - Pandemic and All Hazards Preparedness Act - provisions relating to influenza vaccine innovative technologies H.R.4223, S.1002 - Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act (SAFE DOSES) provisions related to supply chain security H.R.1483 - The Drug Safety Enhancement Act of 2011 - provisions related to supply chain security H.R.1930, S.1799 - Access to Appropriate Immunizations for Veterans Act of 2011 - provisions related to extending VA performance measure to include all federally recommended vaccine H.R.3202 - Water Protection and Reinvestment Act - provisions pertaining to pharmaceuticals in the environment H.R.2245, S.296 - Preserving Access to Life-Savings Medicines Act of 2011 - provisions related to drug shortages H.R.2939 - Pharmaceutical Stewardship Act of 2011 - provisions related to drug safety H.R.5651 - Food and Drug Administration Reform Act of 2012 - provisions related to user fee reauthorization and FDA reform S. 3187 - Food and Drug Administration Safety and Innovation Act of 2012 - provisions related to user fee reauthorization and FDA reform H.R.2529, S.1368 - Restoring Access to Medication Act - provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts S.1584 - Drug Safety and Accountability Act of 2011 - provisions related to drug safety No bill # assigned - Federal Food, Drug, and Cosmetic Act - section related to FDA and regulation of nicotine replacement therapies S.1699 - Prescription Drug Cost Reduction Act - provisions related to 340B and drug rebates H.R.3204 - Guidance Accountability and Transparency Act - provisions to set forth interpretation policy of FDA guidance S.810 - Great Ape Protection and Cost Savings Act of 2011 - provisions related to pre-clinical testing H.R.6190 - Asthma Inhalers Relief Act of 2012 - provisions relating to the removal of Essential-Use Designation for epinephrine S.1752 - Freedom to Breath Act of 2011 - provisions relating to the removal of Essential-Use Designation for epinephrine No bill # assigned - Comparative effectiveness policy issues No bill # assigned - Efforts to amend the National Childhood Vaccine Injury Act of 1986 (26 USC 4132(N)) to include any vaccine against seasonal influenza.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN New | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Medicare/Medicaid MMM
S.1699 - Prescription Drug Cost Reduction Act - provisions related to Medicare Part B and drug rebates H.R.999 - Medicare Prescription Drug Savings and Choice Act of 2011 - provisions related to Medicare Part D H.R.2190 - Medicare Drug Savings Act of 2011 - provisions related to Medicare Part D H.R.452 - Medicare Decisions Accountability Act - provisions related to the Independent Payment Advisory Board (IPAB) S.668 - Health Care Bureaucrats Elimination Act - provisions related to the Independent Payment Advisory Board (IPAB) S.1206 - Medicare Prescription Drug Savings Act of 2011 - provisions related to Medicare Part D S.1251 - Medicare and Medicaid FAST Act - provisions related to Part D issues H.R.1063 - Strengthening Medicare & Repaying Taxpayers Act of 2011 - provisions relating to reform of Secondary Payer rules No bill # assigned - Dual eligibles coordination policy issues No bill # assigned - Deficit reduction policy issues No bill # assigned - Medicaid Program, Covered Outpatient Drugs rulemaking No bill # assigned - Medicare, Medicaid, Children's Health Insurance Programs,; Transparency Reports and Reporting of Physician Ownership or Investment Interests rulemaking
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN New | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Budget/Appropriations BUD
H.R. Res. 117 - Fiscal 2013 Continuing Appropriations Resolution S. 3295 - Fiscal Year 2013 Labor-HHS-Education Appropriations Act - provisions relating to Vaccine Section 317 program, Ryan White CARE Act H.R. 2693 - Budget Control Act of 2011 - sequestration implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN DEL GIORNO | — |
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | HHS, IOS (CAOES, SAOCS) 07-09 |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.